Trial intelligence / Profile preview

Autologous Dental Pulp Stem Cells for Alveolar Bone Regeneration

jRCTb040230035Recruiting

Start
Jun 2023
Countries
1
01

Overview

Open-label, single-arm trial in Alveolar bone atrophy (ABL). Primary endpoint: Safety. Started Jun 2023; status: recruiting.

02

Conditions

Alveolar bone atrophy (ABL)

Beyond the preview

Go deeper on jRCTb040230035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTb040230035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call